A team of investigators from the Cleveland Clinic developed a prospective registry of all patients tested for COVID-19 in their health system that was used to validate a model to predict the risk of an individual having a positive COVID-19 test result.
A team of investigators from Bergamo, Italy, report on the findings of their study on the incidence of Kawasaki-like disease in children during the COVID-19 pandemic.
A study revealed that primary care clinicians do not closely follow clinical practice guidelines with regard to antibiotic prescribing for acute sinusitis and frequently overprescribe antibiotics.
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
A National Institutes of Health-led clinical trial evaluating hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) has been halted after a data and safety monitoring board determined that the drug was unlikely to benefit hospitalized patients.
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
A phase 1 study evaluating the safety, reactogenicity and immunogenicity of SCB-2019, a vaccine candidate for coronavirus disease 2019 (COVID-19), has been initiated by Clover Biopharmaceuticals.
Face-mask use by the public, in combination with physical distancing and periods of lockdown, can mitigate the spread of the new coronavirus.
Regeneron has initiated its first human clinical trials evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention and treatment of coronavirus disease 2019 (COVID-19).
Eight cities with substantial community outbreaks of COVID-19 are distributed along restricted latitude, temperature, and humidity measurements.
